Statement of Main Findings Arising from Systematic Review

  • Sanchia S. Goonewardene
  • Raj Persad


Prostate cancer survivorship was the focus of research in all 27 studies. The systematic review highlighted the following key components of Survivorship Care with erectile dysfunction, as the greatest concern (Figs. 36.1 and 36.2).


  1. 1.
    Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Moller H. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer. 2009;101:541–7.CrossRefGoogle Scholar
  2. 2.
    Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin PW, Sanda MG. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology. 2006;68:166–71.CrossRefGoogle Scholar
  3. 3.
    Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005;17:307–19.CrossRefGoogle Scholar
  4. 4.
    Rosen RC. Sexual function assessment in the male: physiological and self-report measures. Int J Impot Res. 1998;10:S59–63.CrossRefGoogle Scholar
  5. 5.
    O’Brien R, Rose P, Campbell C, Weller D, Neal RD, Wilkinson C, McIntosh H, Watson E. “I wish I’d told them”: a qualitative study examining the unmet psychosexual needs of prostate cancer patients during follow-up after treatment. Patient Educ Couns. 2011;84:200–7.CrossRefGoogle Scholar
  6. 6.
    Goonewardene SS, Persad R, Young A, Grover L, Makar A. Prostate cancer survivorship and psychosexual care. Eur J Cancer Care (Engl). 2015;24(2):281–2.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Sanchia S. Goonewardene
    • 1
  • Raj Persad
    • 2
  1. 1.The Royal Free Hospital and UCLLondonUnited Kingdom
  2. 2.North Bristol NHS TrustBristolUnited Kingdom

Personalised recommendations